2d
MedPage Today on MSNFDA's Deadline Ignored in Nearly 30% of Device Safety ReportsThe FDA has allowed a substantial amount of late reports and undated reports into its Manufacturer and User Facility Device ...
One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...
Hosted on MSN8d
FDA issues early alert for Baxter’s Spectrum infusion pumpThe US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter ...
FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...
We are looking into a health alert, as the FDA has ruled compounded versions of popular drugs used for weight loss will no longer be available.
We are looking into a health alert, as the FDA has ruled compounded versions of popular drugs used for weight loss will no longer be available.
According to the agency, the 15-year-old company only presented efficacy claims for its branded medication and did not include any warnings or precautions for the tablets at a tradeshow.
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and ...
The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter Sigma Spectrum and Spectrum IQ infusion pumps. The agency’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results